Effects of methylmercury on dopamine release in MN9D neuronal cells

References

• Basu N, Klenavic K, Gamberg M, et al. (2005a). Effects of mercury on neurochemical receptor-binding characteristics in wild mink. Environ Toxicol Chem 24:1444–50
   PubMed Web of Science ®Google Scholar
• Basu N, Scheuhammer A, Grochowina N, et al. (2005b). Effects of mercury on neurochemical receptors in wild river otters (Lontra canadensis). Environ Sci Technol 39:3585–91
   PubMed Web of Science ®Google Scholar
• Beyrouty P, Stamler CJ, Liu JN, et al. (2006). Effects of prenatal methylmercury exposure on brain monoamine oxidase activity and neurobehaviour of rats. Neurotoxicol Teratol 28:251–9
   PubMed Web of Science ®Google Scholar
• Bonuccelli U, Piccini P, Del Dotto P, et al. (1990). Platelet monoamine oxidase B activity in parkinsonian patients. J Neurol Neurosurg Psychiatry 53:854–55
   PubMed Web of Science ®Google Scholar
• Chakrabarti SK, Loua KM, Bai C, et al. (1998). Modulation of monoamine oxidase activity in different brain regions and platelets following exposure of rats to methylmercury. Neurotoxicol Teratol 20:161–8
   PubMed Web of Science ®Google Scholar
• Choi HK, Won LA, Kontur PJ, et al. (1991). Immortalization of embryonic mesencephalic dopaminergic neurons by somatic cell fusion. Brain Res 552:67–76
   PubMed Web of Science ®Google Scholar
• Clarkson TW. (1972). The pharmacology of mercury compounds. Annu Rev Pharmacol 12:375–406
   PubMedGoogle Scholar
• Clarkson TW, Magos L. (2006). The toxicology of mercury and its chemical compounds. Crit Rev Toxicol 36:609–62
   PubMed Web of Science ®Google Scholar
• Conway K, Rochet J, Bieganski R, Lansbury PJ. (2001). Kinetic stabilization of the alpha-synuclein protofibril by a dopamine-alpha-synuclein adduct. Science 294:1346–9
   PubMed Web of Science ®Google Scholar
• Cui H, Ye J, Chen Y, et al. (2006). Microelectrode array biochip: tool for in vitro drug screening based on the detection of a drug effect on dopamine release from PC12 cells. Anal Chem 78:6347–55
   PubMed Web of Science ®Google Scholar
• Egaña L, Cuevas R, Baust T, et al. (2009). Physical and functional interaction between the dopamine transporter and the synaptic vesicle protein synaptogyrin-3. J Neurosci 29:4592–604
   PubMed Web of Science ®Google Scholar
• Elsworth JD, Roth RH. (1997). Dopamine synthesis, uptake, metabolism, and receptors: relevance to gene therapy of Parkinson's disease. Exp Neurol 144:4–9
   PubMed Web of Science ®Google Scholar
• Faro L, Do Nascimento JL, Alfonso M, Durán R. (2002). Mechanism of action of methylmercury on in vivo striatal dopamine release. Possible involvement of dopamine transporter. Neurochem Int 40:455–65
   PubMed Web of Science ®Google Scholar
• Faro L, Durán R, Do Nascimento J, et al. (2003). Effects of successive intrastriatal methylmercury administrations on dopaminergic system. Ecotoxicol Environ Saf 55:173–7
   PubMed Web of Science ®Google Scholar
• Faro L, Rodrigues K, Santana M, et al. (2007). Comparative effects of organic and inorganic mercury on in vivo dopamine release in freely moving rats. Braz J Med Biol Res 40:1361–5
   PubMed Web of Science ®Google Scholar
• Fitsanakis VA, Aschner M. (2005). The importance of glutamate, glycine, and gamma-aminobutyric acid transport and regulation in manganese, mercury and lead neurotoxicity. Toxicol Appl Pharmacol 204:343–54
   PubMed Web of Science ®Google Scholar
• Fountaine TM, Wade-Martins R. (2007). RNA interference-mediated knockdown of alpha-synuclein protects human dopaminergic neuroblastoma cells from MPP(+) toxicity and reduces dopamine transport. J Neurosci Res 85:351–63
   PubMed Web of Science ®Google Scholar
• Gomes B, Kloepfer HG, Oi S, Yasunobu KT. (1976). The reaction of sulfhydryl reagents with bovine hepatic monoamine oxidase. Evidence for the presence of two cysteine residues essential for activity. Biochim Biophys Acta 438:347–57
   PubMed Web of Science ®Google Scholar
• Heikkila R, Manzino L, Cabbat F, Duvoisin R. (1984). Protection against the dopaminergic neurotoxicity of 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine by monoamine oxidase inhibitors. Nature 311:467–9
   PubMed Web of Science ®Google Scholar
• Hermanson E, Joseph B, Castro D, et al. (2003). Nurr1 regulates dopamine synthesis and storage in MN9D dopamine cells. Exp Cell Res 288:324–34
   PubMed Web of Science ®Google Scholar
• Hussain S, Hass BS, Slikker JrW, Ali SF. (1999). Reduced levels of catalase activity potentiate MPP+-induced toxicity: comparison between MN9D cells and CHO cells. Toxicol Lett 104:49–56
   PubMed Web of Science ®Google Scholar
• Jethva PN, Kardani JR, Roy I. (2011). Modulation of alpha-synuclein aggregation by dopamine in the presence of MPTP and its metabolite. FEBS J 278:1688–98
   PubMed Web of Science ®Google Scholar
• Jones DC, Miller GW. (2008). The effects of environmental neurotoxicants on the dopaminergic system: a possible role in drug addiction. Biochem Pharmacol 76:569–81
   PubMed Web of Science ®Google Scholar
• Kim IS, Choi DK, Jung HJ. (2011). Neuroprotective effects of vanillyl alcohol in gastrodia elata blume through suppression of oxidative stress and anti-apoptotic activity in toxin-induced dopaminergic MN9D cells. Molecules 16:5349–61
   PubMed Web of Science ®Google Scholar
• Kühn K, Wellen J, Link N, et al. (2003). The mouse MPTP model: gene expression changes in dopaminergic neurons. Eur J Neurosci 17:1–12
   PubMed Web of Science ®Google Scholar
• Lee E, Soliman K, Charlton C. (2005). Lysophosphatidylcholine decreases locomotor activities and dopamine turnover rate in rats. Neurotoxicology 26:27–38
   PubMed Web of Science ®Google Scholar
• Lewers JC, Ceballos-Picot I, Shirley TL, et al. (2008). Consequences of impaired purine recycling in dopaminergic neurons. Neuroscience 152:761–72
   PubMed Web of Science ®Google Scholar
• Liu D, Jin L, Wang H, et al. (2008). Silencing alpha-synuclein gene expression enhances tyrosine hydroxylase activity in MN9D cells. Neurochem Res 33:1401–9
   PubMed Web of Science ®Google Scholar
• Michalke B, Halbach S, Nischwitz V. (2009). JEM spotlight: metal speciation related to neurotoxicity in humans. J Environ Monit 11:939–54
   PubMed Web of Science ®Google Scholar
• Miyamoto K, Nakanishi H, Moriguchi S, et al. (2001). Involvement of enhanced sensitivity of N-methyl-d-aspartate receptors in vulnerability of developing cortical neurons to methylmercury neurotoxicity. Brain Res 901:252–8
   PubMed Web of Science ®Google Scholar
• Nakai M, Mori A, Watanabe A, Mitsumoto Y. (2003). 1-Methyl-4-phenylpyridinium (MPP+) decreases mitochondrial oxidation-reduction (REDOX) activity and membrane potential (Deltapsi(m)) in rat striatum. Exp Neurol 179:103–10
   PubMed Web of Science ®Google Scholar
• Ndountse L, Chan H. (2008). Methylmercury increases N-methyl-d-aspartate receptors on human SH-SY 5Y neuroblastoma cells leading to neurotoxicity. Toxicology 249:251–5
   PubMed Web of Science ®Google Scholar
• Ninomiya T, Ohmori H, Hashimoto K, et al. (1995). Expansion of methylmercury poisoning outside of Minamata: an epidemiological study on chronic methylmercury poisoning outside of Minamata. Environ Res 70:47–50
   PubMed Web of Science ®Google Scholar
• Paleologou KE, Irvine GB, El-Agnaf OM. (2005). Alpha-synuclein aggregation in neurodegenerative diseases and its inhibition as a potential therapeutic strategy. Biochem Soc Trans 33:1106–10
   PubMed Web of Science ®Google Scholar
• Perez R, Waymire J, Lin E, Liu J, et al. (2002). A role for alpha-synuclein in the regulation of dopamine biosynthesis. J Neurosci 22:3090–9
   PubMed Web of Science ®Google Scholar
• Roos PM, Vesterberg O, Nordberg M. (2006). Metals in motor neuron diseases. Exp Biol Med 231:1481–7
   Web of Science ®Google Scholar
• Spittau B, Zhou X, Ming M, Krieglstein K. (2012). IL6 protects MN9D cells and midbrain dopaminergic neurons from MPP+-induced neurodegeneration. Neuromol Med 14:317–27
   PubMed Web of Science ®Google Scholar
• Stamler CJ, Abdelouahab N, Vanier C, et al. (2006). Relationship between platelet monoamine oxidase-B (MAO-B) activity and mercury exposure in fish consumers from the Lake St. Pierre region of Quebec, Canada. Neurotoxicology 27:429–36
   PubMed Web of Science ®Google Scholar
• Stamler CJ, Basu N, Chan HM. (2005). Biochemical markers of neurotoxicity in wildlife and human populations: considerations for method development. J Toxicol Environ Health A 68:1413–29
   PubMed Web of Science ®Google Scholar
• Tehranian R, Montoya S, Van Laar A, et al. (2006). Alpha-synuclein inhibits aromatic amino acid decarboxylase activity in dopaminergic cells. J Neurochem 99:1188–96
   PubMed Web of Science ®Google Scholar
• Thiffault C, Langston JW, DI Monte DA. (2000). Increased striatal dopamine turnover following acute administration of rotenone to mice. Brain Res 885:283–8
   PubMed Web of Science ®Google Scholar
• Vettori M, Goldoni M, Caglieri A, et al. (2006). Antagonistic effects of methyl-mercury and PCB153 on PC12 cells after a combined and simultaneous exposure. Food Chem Toxicol 44:1505–12
   PubMed Web of Science ®Google Scholar
• Vicente-Torres M, Gil-Loyzaga P, Carricondo F, Bartolomé M. (2002). Simultaneous HPLC quantification of monoamines and metabolites in the blood-free rat cochlea. J Neurosci Methods 119:31–6
   PubMed Web of Science ®Google Scholar
• Vila M, Vukosavic S, Jackson-Lewis V, et al. (2000). Alpha-synuclein up-regulation in substantia nigra dopaminergic neurons following administration of the parkinsonian toxin MPTP. J Neurochem 74:721–9
   PubMed Web of Science ®Google Scholar
• Wang J, Duhart H, Xu Z, et al. (2008). Comparison of the time courses of selective gene expression and dopaminergic depletion induced by MPP+ in MN9D cells. Neurochem Int 52:1037–43
   PubMed Web of Science ®Google Scholar
• Wersinger C, Prou D, Vernier P, Sidhu A. (2003). Modulation of dopamine transporter function by alpha-synuclein is altered by impairment of cell adhesion and by induction of oxidative stress. FASEB J 17:2151–3
   PubMed Web of Science ®Google Scholar
• Wu B, Liu Q, Duan C, et al. (2011). Phosphorylation of alpha-synuclein upregulates tyrosine hydroxylase activity in MN9D cells. Acta Histochem 113:32–5
   PubMed Web of Science ®Google Scholar
• Xu Z, Cawthon D, Mccastlain K, et al. (2005). Selective alterations of gene expression in mice induced by MPTP. Synapse 55:45–51
   PubMed Web of Science ®Google Scholar
• Yang YJ, Wang QM, Hu LF, et al. (2006). Iptakalim alleviated the increase of extracellular dopamine and glutamate induced by 1-methyl-4-phenylpyridinium ion in rat striatum. Neurosci Lett 404:187–90
   PubMed Web of Science ®Google Scholar
• Youdim MB, Bakhle YS. (2006). Monoamine oxidase: isoforms and inhibitors in Parkinson's disease and depressive illness. Br J Pharmacol 147:S287–96
   PubMed Web of Science ®Google Scholar
• Youdim MB, Riederer PF. (2004). A review of the mechanisms and role of monoamine oxidase inhibitors in Parkinson's disease. Neurology 63:S32–5
   PubMed Web of Science ®Google Scholar
• Yuan Y, Jin J, Yang B, et al. (2008). Overexpressed alpha-synuclein regulated the nuclear factor-kappaB signal pathway. Cell Mol Neurobiol 28:21–33
   PubMed Web of Science ®Google Scholar
• Zhang TA, Placzek AN, Dani JA. (2010). In vitro identification and electrophysiological characterization of dopamine neurons in the ventral tegmental area. Neuropharmacology 59:431–6
   PubMed Web of Science ®Google Scholar
• Zhou M, Panchuk-Voloshina N. (1997). A one-step fluorometric method for the continuous measurement of monoamine oxidase activity. Anal Biochem 253:169–74
   PubMed Web of Science ®Google Scholar
• Zhou Z, Yap B, Gung A, et al. (2006). Dopamine-related and caspase-independent apoptosis in dopaminergic neurons induced by overexpression of human wild type or mutant a-synuclein. Exp Cell Res 312:156–70
   PubMed Web of Science ®Google Scholar